Contract 75A50121C00024
Cepheid · Department Of Health And Human Services · September 27, 2024
Cepheid was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2024 for $31.93 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Sunnyvale, CA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost no fee contract pricing. The most recent modification was on March 2, 2026. If all options are exercised, the contract could reach $103.58 million.
Contract details
- PIID
- 75A50121C00024
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- General Science & Technology R&D Svcs; General Science & Technology; R&D Administrative Expenses
- Place of performance
- Sunnyvale, CA
- First action
- September 27, 2024
- Latest action
- March 2, 2026
Description
OTA - PANDEMIC PREPAREDNESS AND RESPONSE: ESTABLISHING A PLATFORM FOR DIAGNOSIS AND SURVEILLANCE OF EMERGING THREATS
Modification timeline
-
March 2, 2026Mod P00009 · Supplemental Agreement For Work Within Scope$74.98M
-
December 22, 2025Mod P00008 · Other Administrative Action$74.98M
-
August 18, 2025Mod P00007 · Supplemental Agreement For Work Within Scope$74.98M
-
September 27, 2024Mod P00005 · Supplemental Agreement For Work Within Scope$74.98M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50121C00024?
Contract 75A50121C00024 is a federal contract awarded to Cepheid by Department Of Health And Human Services on September 27, 2024 for $31.93 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75A50121C00024?
Cepheid won contract 75A50121C00024 from Department Of Health And Human Services.
How much is contract 75A50121C00024 worth?
Contract 75A50121C00024 has obligated $31.93 million to date, with a total potential value of $103.58 million if all options are exercised.